|
| Press Releases |
|
 |
|
| Tuesday, June 7, 2022 |
|
|
Novotech助力Endpoints ASCO 2022年專家組，加速中國腫瘤臨床試驗 |
| Novotech是亞太地區領先的生物技術臨床研究機構，近期入駐美國，助力Endpoints ASCO 2022年專家組，加速中國和美國臨床試驗進程。 more info >> |
|
|
Novotech助力Endpoints ASCO 2022年专家组，加速中国肿瘤临床试验 |
| Novotech是亚太地区领先的生物技术临床研究机构，近期入驻美国，助力Endpoints ASCO 2022年专家组，加速中国和美国临床试验进程。 more info >> |
|
| Monday, June 6, 2022 |
|
|
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China |
| Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO 22 "Accelerating clinical development in China and the US". more info >> |
|
| Friday, June 3, 2022 |
|
|
노보텍, 초기 단계 종양학 임상 및 미-중 규제 전략에 관한 프리-ASCO 중국 서밋의 전문가 패널들을 후원 |
| 최근 미국으로 서비스를 확장한 바 있는 아시아 태평양 지역 바이오테크 전문 임상 시험수탁기관(CRO)인 노보텍(Novotech)은 중국과 미국의 종양학 약물 전문가가 참여하는 2022년 프리-ASCO 중국 서밋의 전문가 패널들을 후원했다. more info >> |
|
|
Novotech 贊助 ASCO 中國峰會前中美早期腫瘤試驗和監管策略專家組 |
| Novotech 是亞太地區領先的生物技術專家 CRO，最近將其服務擴展到美國，在 2022 年 ASCO 前中國峰會上贊助了專家小組，匯集了中國和美國腫瘤藥物開發的領導者。 Pre-ASCO 系列在全球有超過 20,000 人觀看。 more info >> |
|
|
Novotech 赞助 ASCO 中国峰会前中美早期肿瘤试验和监管策略专家组 |
| Novotech 是亚太地区领先的生物技术专家 CRO，最近将其服务扩展到美国，在 2022 年 ASCO 前中国峰会上赞助了专家小组，汇集了中国和美国肿瘤药物开发的领导者。 more info >> |
|
| Thursday, June 2, 2022 |
|
|
Novotech Sponsors Pre-ASCO China Summit Panels on Early Phase Oncology Trials, Regulatory Strategy for China and US |
| Novotech, the leading Asia Pacific biotech specialist CRO with recently expanded services to the US, sponsored expert panels at the Pre-ASCO China Summit 2022, bringing together leaders in oncology drug development in China and the US. more info >> |
|
| Thursday, May 12, 2022 |
|
|
노보텍, 프리-ASCO중국 서밋 후원: 초기 단계 종양학 임상에 기반해 진행 여부 결정 |
| 최근 미국으로 서비스를 확장한 바 있는 아시아 태평양 지역 바이오테크 전문 임상시험수탁기관(CRO)인 노보텍(Novotech)은 '초기 단계 종양학 임상에 기반해 진행 여부 결정'이라는 제목의 2022년 프리-ASCO 중국 서밋(이하 '서밋')을 후원하게 된다. more info >> |
|
|
Novotech 贊助 ASCO 中國峰會前夕：基於早期腫瘤學試驗的 Go/No Go 決策 |
| Novotech 是亞太地區領先的生物技術專家 CRO，最近將其 CRO 服務擴展到美國，很高興贊助 2022 年 ASCO 中國峰會前活動，題為：基於早期腫瘤試驗的 Go/No Go Decisions（“峰會”）。 more info >> |
|
|
Novotech 赞助 ASCO 中国峰会前夕：基于早期肿瘤学试验的 Go/No Go 决策 |
| Novotech 是亚太地区领先的生物技术专家 CRO，最近将其 CRO 服务扩展到美国，很高兴赞助 2022 年 ASCO 中国峰会前活动，题为：基于早期肿瘤试验的 Go/No Go Decisions（“峰会”）。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Fujitsu drives chemical industry logistics DX with participation in joint logistics demonstration
Dec 23, 2024 13:30 JST
|
|
|
中國核電榮膺中國證券「金紫荊獎」兩項大獎
Dec 23, 2024 12:24 HKT/SGT
|
|
|
広汽Hondaの開発区新エネルギー車工場が稼働開始
Dec 23, 2024 11:30: JST
|
|
|
吳佩慈男友紀曉波發聲明 否認參與緬甸「恒升園區」
Dec 23, 2024 11:29 HKT/SGT
|
|
|
吴佩慈男友纪晓波发声明 否认参与缅甸「恒升园区」
Dec 23, 2024 11:27 HKT/SGT
|
|
|
Seamless HDB Renovations: How 2 Design Combines Expertise with In-House Solutions
Dec 23, 2024 11:00: JST
|
|
|
富士通など、モダナイゼーションに特化したファイナンスサービスを提供開始
Dec 23, 2024 10:30: JST
|
|
|
Seamless HDB Renovations: How 2 Design Combines Expertise with In-House Solutions
Dec 23, 2024 10:00 HKT/SGT
|
|
|
Summit Group Responds to White Paper Citing Governance Issues in Bangladesh's Power and Energy Sector
Dec 23, 2024 09:00 HKT/SGT
|
|
|
TechGALA 2025 - 愛知縣首屆國際初創企業大會
Dec 23, 2024 08:00 HKT/SGT
|
|
|
The finest places to live, work, and thrive in Asia are celebrated at the 19th PropertyGuru Asia Property Awards Grand Final
Dec 23, 2024 07:50 HKT/SGT
|
|
|
Mainland China, Hong Kong, Macau companies triumph at finale of 2024 PropertyGuru Asia Property Awards
Dec 22, 2024 20:50 HKT/SGT
|
|
|
The 2024 PropertyGuru Asia Property Awards International Luncheon celebrates real estate achievements in the Middle East and South Asia
Dec 22, 2024 19:30 HKT/SGT
|
|
|
Virturo Elite Club: Unlock Exclusive Wealth-Building Opportunities for High-Net-Worth Individuals
Dec 21, 2024 09:30: JST
|
|
|
Pathwizz Redefines Trust in Digital Transactions with Award-Winning Support and Verified Platforms 'Wizz Support'
Dec 21, 2024 09:00: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
